[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.241.199. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 766
Citations 0
Invited Commentary
January 2015

Defining Success With Antiretroviral Therapy

Author Affiliations
  • 1Department of Medicine, University of Minnesota, Minneapolis
JAMA Intern Med. 2015;175(1):99-100. doi:10.1001/jamainternmed.2014.4004

Two critically important issues in human immunodeficiency virus (HIV) therapeutics are when to start antiretroviral therapy and how well these medications restore immunity. In this issue of JAMA Internal Medicine, Okulicz et al1 describe a prospective cohort study of 1119 US military service persons with known seroconversion dates who were monitored for several years. Because the dates of seroconversion were known for these individuals and their immunologic status was well characterized, the data from this valuable cohort enable us to better answer these fundamental questions about HIV treatment.

First Page Preview View Large
First page PDF preview
First page PDF preview
×